Coordinated regulation of p31Comet and Mad2 expression is required for cellular proliferation |
| |
Authors: | Dipali A Date Amy C Burrows Monica Venere Mark W Jackson Matthew K Summers |
| |
Affiliation: | 1.Department of Cancer Biology; Lerner Research Institute; Cleveland, OH USA;2.Department of Stem Cell Biology and Regenerative Medicine; Lerner Research Institute; Cleveland, OH USA;3.Department of Pathology; Case Western Reserve University; Cleveland, OH USA;4.Case Comprehensive Cancer Center; Case Western Reserve University; Cleveland, OH USA |
| |
Abstract: | p31Comet is a well-known interacting partner of the spindle assembly checkpoint (SAC) effector molecule Mad2. At the molecular level it is well established that p31Comet promotes efficient mitotic exit, specifically the metaphase–anaphase transition, by antagonizing Mad2 function. However, there is little knowledge of how p31Comet is regulated or the physiological importance of controlling p31Comet. Here, we show that the Rb–E2F pathway regulates p31Comet expression. In multiple tumor types (including breast and lung) p31Comet expression is increased along with Mad2. Expression of this antagonist–target pair is coordinated in cells and correlated in cancer. Moreover, a narrow range of p31Comet:Mad2 ratios is compatible with cellular viability. Our data suggest that coordinate regulation is important for the outgrowth of oncogenic cell populations. Our findings suggest that altered p31Comet:Mad2 expression ratios may provide new insight into altered SAC function and the generation of chromosomal instability in tumors. |
| |
Keywords: | cancer cell cycle spindle assembly checkpoint E2F Rb Mad2 p31Comet |
|
|